Alembic Pharma surges on USFDA completing inspection at its Bioequivalence facility

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 520.00, up by 9.65 points or 1.89% from its previous closing of Rs. 510.35 on the BSE. The scrip opened at Rs. 520.00 and has touched a high and low of Rs. 525.80 and Rs. 517.15 respectively. The BSE group ‘A’ stock of face value Rs. 2 has … Read more

LPG Users Alert: Complete eKYC by August 16 Magic Photo Editor drops ₹12,579 before Pixel 11 launch! Jio’s Best Offer: Free WiFi for 1 Month, 100Mbps Internet!